key: cord-279875-jxnszm5k
authors: Wang, Wan-Ying; Xie, Ying; Zhou, Hua; Liu, Liang
title: Contribution of traditional Chinese medicine to the treatment of COVID-19
date: 2020-07-07
journal: Phytomedicine
DOI: 10.1016/j.phymed.2020.153279
sha: 
doc_id: 279875
cord_uid: jxnszm5k

COVID-19 as an epidemic disease has spread across the planet since December 2019. The somber situation reminds each country to take actions in preventing the spreading of the virus. China as one of the early affected countries has been fighting against the novel coronavirus with the achievements of nearly 80,000 cured confirmed patients. Traditional Chinese medicine (TCM) has made contributions to the treatment of COVID-19 because of its efficacy and comprehensive therapeutic theory. In this commentary, the advantage, aetiology and mechanism of TCM therapy were discussed in the aspect of its functions in reducing the harms brought by COVID-19 to human beings.

The rapid spreading of the 2019 novel coronavirus (SARS-COV-2) has resulted in an outbreak of coronavirus disease 2019 in over 200 countries globally. As of the World Health Organization (WHO) situation report on May 24, 2020, there were 5,204,508 confirmed cases all over the world, among them, 84,525 cases in China and 5,119,983 cases in locations outside China. (World Health Organization, 2020) The extensive attention to such an epidemic disease originated from several patients with severe pneumonia in Wuhan, China in January 2020. Although the situation in China has almost reached steady since March, the number of confirmed cases outside China has boosted in other regions, with 2,338,124 confirmed cases in Americas and 2,006,984 confirmed cases in Europe. (Fig.1) . The unique features of COVID-19 are the fast transmission, difficulty to cure and a lack of proper methods of preventing its infection. Common clinical features of confirmed patients are fever and cough. (Guan et al., 2020) The diagnosis is confirmed by their clinical, laboratory, and radiological features and then further divided into mild, severe and critically ill according to their symptoms. (Li and De Clercq, 2020) However, COVID-19 has killed more people than the combined number of cases with SARS and MERS. (Mahase, 2020) In China, traditional Chinese medicine (TCM) is concurrently playing an important role in the treatment of COVID-19, integrated with modern imaging system, first-aid facility and ordinary chemical therapy. (Yang, 2020) The national percentage of treating confirmed cases of COVID-19 patients with TCM-integrated therapy is over 90% with the support from over 4900 TCM practitioners all over China. Each mobile cabin hospital is equipped with 2-3 TCM experts and a team of 12 national TCM masters are accompanied with severe patients in Wuhan.(Liu，Ruiche, 2020) Currently, the national treatment guidance of COVID-19 (7 th edition) (General Office of the National Health Commission, 2020) and more than 20 provinces and regions have released modified treatment guidance inclining TCM integration according to their geographical and weather conditions, which is an unique methodology in TCM therapy based on the perspective of harmonization between environment and human body. Each guidance has emphasized in detail that TCM therapy should be integrated with chemical therapy and TCM practitioners should be involved in the consultation system with no exception. The advantages of TCM-integrated therapy Based on the clinical data from the TCM practitioners treating patients in Wuhan, the dominant advantages of TCM-integrated therapy include shortening rehabilitation period and decreasing the transferring rate from the mild to severe or critically ill cases. (Yang, 2020) In a clinical experiment (first batch of clinical data involving TCM treatment) of 52 confirmed cases, of which 34 cases were treated with TCM-integrated therapy with chemical. It was reported that the length of treatment of COVID-19 patients would be 5.15 days in TCM-integrated treatment group, which is 2 days shorter than that in chemical drugs therapy.

TCM-integrated therapy could also increase around 30% clinical cure rate. The rate of mild patients transferred to severe patients of TCM-integrated treatment is 29% less than that of group treated by chemical drugs only. (Wu, 2020) As reported from Prof. Tong, the total effective rate of Qingfeipaidu formula could reach 97.78% in a statistics of 1261 COVID-19 patients and no patients transferred to severe or critically ill cases. (Zhao, 2020) For those severe COVID-19 patients, TCM-integrated therapy could shorten the duration of virus nucleic acid test from positive to negative, which means the patients could be discharged from hospital 2 days earlier. Technically, the clinical indexes including oxyhemoglobin saturation, lymphocyte percentage and lactate dehydrogenase are all improved substantially when patients are treated with TCM-integrated therapy. (Wang, 2020) In addition, the combinational TCM formulae could also help alleviate the adverse drug reactions induced by anti-virus drugs and corticosteroids, especially in gastrointestinal and hepatic related systems. Therefore, an early and full-dimensional intervention of TCM therapy could achieve a better outcome of the treatment.

Since COVID-19 could be infected through droplet from human to human in a diverse age range, this disease could be included as "pestilence" in TCM theory. January is the coldest month over a year and the rainfall of Wuhan in January is nearly 5 times of the mean rainfall during the same period in the past 20 years.(Weatheronline) Low fever, dry cough, debilitation, whole-body sore, nausea, diarrhea and diarrhea are common symptoms of COVID-19 patients which correlate with "cold and damp" symptoms in TCM theory.

Therefore, a qualitative definition of COVID-19 in TCM theory is a "cold and damp" (Chen and Nakamura, 2004; Jia and Gao, 2003) Using a different idea from the microbiology-oriented knowledge of the aetiology of the disease or the mechanism of novel drugs, TCM emphasizes on the relief of symptoms so as to cure infected patients and control the spreading of epidemics.

COVID-19 was defined as a self-limited disease and severe immune injury is one of the characterized pathological features of reported cases. The enhancement of patients' immunity is therefore a crucial contributor of their recovery (Stebbing et al., 2020) , which highly correlates with TCM theory. The mechanism of TCM-integrated therapy starts from the diagnosis of the disease. The criteria of confirming COVID-19 cases is unified according to their serum samples and CT images from mild patients to critically ill cases.(General Office of the National Health Commission, 2020) However, over 20% of the patients might have at least one coexisting disease with COVID-19. (Guan et al., 2020) Patients are then further classified by their personal symptoms with high specificity treated with TCM-integrated therapy. In this way, TCM patent medicine or TCM combinational formulae could be prescribed to corresponding patients with different symptoms.

Locally in the organs, invigorating the circulation of blood in lung is the main issue but the balance between lung, spleen and organs in the gastrointestinal system is also emphasized in TCM theory. According to the national guidance of COVID-19 treatment, a number of TCM patent medicine were recommended during medical observation period including Jinhuaqinggan granules were found to be associated with multiple signaling pathways treating COVID-19 through in silico analysis, such as TNF signaling pathway, MAPK signaling pathway, T cell receptor signaling pathway and so on. Lianhuaqingwen granules could significantly relieve clinical symptoms in COVID-19 patients by inhibiting the release of inflammatory mediators so as to regulate the immune response of virus infection. (Ding et al., 2017; Dong et al., 2014; Similarly, Shufengjiedu capsule could also ameliorate upper respiratory tract infection via the ERK pathway and modulate anti-inflammatory and immunomodulation activity. Tao et al., 2017) For those severe COVID-19 patients, the holistic perspective of TCM could be responsible Inhibit IFN-γ, NF-κB and NLRP3 signaling pathways so as to reduce the inflammatory response. (Paoletti et al., 2013; Zhang et al., 2017) . These reports provided the scientific ground of integrating TCM therapy from the aspects of their compositions' potential targeting proteins and signaling pathways in the treatment of COVID-19.

There are still no effective countermeasures to defeat COVID-19 from the understanding of the pathology to the development of drugs or vaccines. Currently, the number of newly confirmed COVID-19 patients is largely decreasing and the number of cured patients is increasing in China attributing to the effective therapeutic regimen which cannot ignore the integration of TCM therapy. In the future, more clinical cases of COVID-19 could be concluded in the statistics to decipher the pathology of the disease. Meanwhile, the mechanism of existing or novel drugs for COVID-19 treatment could be further evaluated.

The clinical experience of treating COVID-19 could hopefully be adopted as a reference by other affected countries, especially the TCM-integrated therapy to address current crisis.

Acknowledgement: This research was funded by the Science and Technology Development Situation Report -125) (World Health Organization, 2020)

Effect of Xiao-Chai-Hu decoction with different doses of Bupleurum on body temperature and content of IL-1β, IL-6, TNF-α in serum induced by LPS among fever rat models

Potential natural compounds for preventing 2019-nCoV infection

Statistical evidence for the usefulness of Chinese medicine in the treatment of SARS

Chinese history of epidemic prevention. Guangxi science and technology press

Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders

The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function

Effect of lianhuaqingwen capsules on airway inflammation in patients with acute exacerbation of chronic obstructive pulmonary disease

Protective effects of saikoside on rats with alcoholic liver disease

Novel coronavirus pneumonia diagnosis and treatment plan

Clinical Characteristics of Coronavirus Disease 2019 in China

Efficacy and Safety of Lianhuaqingwen Capsules, a repurposed Chinese Herb

Is traditional Chinese medicine useful in the treatment of SARS?

On the basis of syndrome differentiation considering the rapid treatment of COVID-19 by Qingfeipaidu decoction

Anti-inflammatory effects of Shufengjiedu capsule for upper respiratory infection via the ERK pathway

Study on network pharmacology of jinhua qinggan granule in the treatment of COVID-19

All the mobile cabin hospitals in Wuhan are equipped with TCM experts

The cytokine storm of severe influenza and development of immunomodulatory therapy

Xiaochaihu decoction attenuates the vicious circle between the oxidative stress and the ALP inactivation through LPS-catecholamines interactions in gut, liver and brain during CCI4+ethanol-induced mouse HCC

The infiltration and apoptosis of eosinophilicand the influence of Fas and Bcl-2 expression after belamcanda and ephedra decoction on asthma rats

Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate

Novel Coronavirus Pneumonia Emergency Response Epidemiology Team

Amygdalin analogues inhibit IFN-γ signalling and reduce the inflammatory response in human epidermal keratinocytes

Baicalein exhibits anti-inflammatory effects via inhibition of NF-κB transactivation

In the treatment of COVID-19, why is traditional Chinese medicine effective?

COVID-19: combining antiviral and anti-inflammatory treatments

The intervention of Sheganmahuang decoction in airway inflammation of asthmatic mice through changing IL-17A and TNF-α

Therapeutic Mechanistic Studies of ShuFengJieDu Capsule in an Acute Lung Injury Animal Model Using Quantitative Proteomics Technology

To explore the TCM prevention and treatment strategies of new coronavirus pneumonia (COVID-19) from the perspective of "cold and damp pestilence

Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP)

Fighting COVID-19 by feeling the pulse. People's Dly

The treatment strategies of Chinese medicine and the participation rate of Chinese medicine treatment in each province and the curative effect of new coronavirus pneumonia

World Health Organization, 2020. Coronavirus disease (COVID-19) Situation Report -125

Traditional Chinese medicine has a definite effect on mild cases and can also assist in the treatment of severe cases of COVID-19

Treatise on Acute Epidemic Febrile Diseases

Inhibitory effects of flavonoids extracted from licorice on lipopolysaccharide-induced acute pulmonary inflammation in mice

Feiyan no.1" prescription used in many designated treatment hospitals in Guangdong

TCM widely used in COVID-19 patient treatment, yielding good results

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Combining TCM,Western medicine effective against virus

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Glycyrrhizin administration ameliorates Streptococcus aureus-induced acute lung injury

Protective effect of Amygdalin on LPS-induced acute lung injury by inhibiting NF-κB and NLRP3 signaling pathways

Academician Tong Xiaolin: The total effective rate of Qingfeipaidu formula was 97%, none transfer from mild to severe cases

Compilation of information on treatment drugs for COVID-19


